Transcriptional profiling of non-small cell lung cancer using oligonucleotide microarrays.

作者信息

Cojocaru Gady, Friedman Nir, Krupsky Meir, Yaron Penina, Simansky David, Yellin Alon, Rechavi Gideon, Barash Yossef, Ben-Dor Amir, Yakhini Zohar, Kaminski Naftali

机构信息

Functional Genomics, Sheba Medical Center, Tel Hashomer, Israel.

出版信息

Chest. 2002 Mar;121(3 Suppl):44S. doi: 10.1378/chest.121.3_suppl.44s.

DOI:10.1378/chest.121.3_suppl.44s

PMID:11893681

Abstract

摘要

相似文献

Transcriptional profiling of non-small cell lung cancer using oligonucleotide microarrays.

Chest. 2002 Mar;121(3 Suppl):44S. doi: 10.1378/chest.121.3_suppl.44s.

Has genetic profiling finally come of age in NSCLC?

Lancet Oncol. 2006 Sep;7(9):699. doi: 10.1016/S1470-2045(06)70836-1.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.

Gene signature for predicting NSCLC outcome.

Lancet Oncol. 2007 Feb;8(2):105. doi: 10.1016/s1470-2045(07)70024-4.

Aspects of lung cancer gene expression profiling.

Curr Opin Drug Discov Devel. 2004 May;7(3):290-303.

[Non small cell lung cancer gene expression profiles by cDNA microarrays].

Hunan Yi Ke Da Xue Xue Bao. 2003 Feb 28;28(1):9-12.

[Association of molecular biology of lung cancers and their metastasis and prognosis].

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):632-4.

Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Cancer Res. 2002 Jun 1;62(11):3005-8.

A high-throughput methodology for identifying molecular targets overexpressed in lung cancers.

Methods Mol Med. 2003;75:177-88. doi: 10.1385/1-59259-324-0:177.

Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?

J Clin Oncol. 2004 Aug 15;22(16):3209-11. doi: 10.1200/JCO.2004.05.931. Epub 2004 Jul 12.

引用本文的文献

The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.

Pharmacogenomics. 2004 Jul;5(5):525-52. doi: 10.1517/14622416.5.5.525.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Transcriptional profiling of non-small cell lung cancer using oligonucleotide microarrays.

Chest. 2002 Mar;121(3 Suppl):44S. doi: 10.1378/chest.121.3_suppl.44s.

Has genetic profiling finally come of age in NSCLC?

Lancet Oncol. 2006 Sep;7(9):699. doi: 10.1016/S1470-2045(06)70836-1.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.

Gene signature for predicting NSCLC outcome.

Lancet Oncol. 2007 Feb;8(2):105. doi: 10.1016/s1470-2045(07)70024-4.

Aspects of lung cancer gene expression profiling.

Curr Opin Drug Discov Devel. 2004 May;7(3):290-303.

[Non small cell lung cancer gene expression profiles by cDNA microarrays].

Hunan Yi Ke Da Xue Xue Bao. 2003 Feb 28;28(1):9-12.

[Association of molecular biology of lung cancers and their metastasis and prognosis].

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):632-4.

Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Cancer Res. 2002 Jun 1;62(11):3005-8.

A high-throughput methodology for identifying molecular targets overexpressed in lung cancers.

Methods Mol Med. 2003;75:177-88. doi: 10.1385/1-59259-324-0:177.

Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?

J Clin Oncol. 2004 Aug 15;22(16):3209-11. doi: 10.1200/JCO.2004.05.931. Epub 2004 Jul 12.

引用本文的文献

The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.

Pharmacogenomics. 2004 Jul;5(5):525-52. doi: 10.1517/14622416.5.5.525.